Literature DB >> 12085966

Metastasis suppression in prostate cancer.

E B Jaeger1, R S Samant, C W Rinker-Schaeffer.   

Abstract

Due to a lack of effective treatments, the development of metastases remains the most lethal aspect of prostate cancer. In order to help overcome this problem there has been an ongoing effort to develop strategies for early intervention. This includes the development of strategies that allow histologic lesions and disseminated cells that are highly likely to cause metastatic disease to be distinguished from those that are not, as well as therapeutic approaches to specifically target bone metastases. Such approaches will be expedited by the identification of genes and signaling cascades that regulate metastatic growth. Genes that specifically suppress metastasis are strong candidates for these studies. This review will focus on metastasis-suppressor genes that have been identified functionally, particularly those found to play a role in prostate cancer, and discuss how the identification and study of these genes has influenced our overall understanding of the metastatic process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12085966     DOI: 10.1023/a:1015587411668

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  8 in total

1.  Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy.

Authors:  Mohammad R Noori-Daloii; Majid Momeny; Mehdi Yousefi; Forough Golsaz Shirazi; Mehdi Yaseri; Nasrin Motamed; Nazanin Kazemialiakbar; Saeed Hashemi
Journal:  Med Oncol       Date:  2010-07-02       Impact factor: 3.064

Review 2.  Molecular pathology of prostate cancer.

Authors:  C Hughes; A Murphy; C Martin; O Sheils; J O'Leary
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer.

Authors:  Meng-Chun Wang; Yan-Min Yang; Xiao-Han Li; Fang Dong; Yan Li
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

4.  A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to bone.

Authors:  Michael Rosenblatt
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

5.  A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth.

Authors:  Yuqing Zhang; Jingxuan Yang; Xiaobo Cui; Yong Chen; Vivian F Zhu; John P Hagan; Huamin Wang; Xianjun Yu; Sally E Hodges; Jing Fang; Paul J Chiao; Craig D Logsdon; William E Fisher; F Charles Brunicardi; Changyi Chen; Qizhi Yao; Martin E Fernandez-Zapico; Min Li
Journal:  EMBO Mol Med       Date:  2013-07-16       Impact factor: 12.137

6.  The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.

Authors:  Anita Yakkundi; Lynn McCallum; Anthony O'Kane; Hayder Dyer; Jenny Worthington; Hayley D McKeen; Lana McClements; Christopher Elliott; Helen O McCarthy; David G Hirst; Tracy Robson
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.752

7.  P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells.

Authors:  W-H Li; Y Qiu; H-Q Zhang; Y Liu; J-F You; X-X Tian; W-G Fang
Journal:  Br J Cancer       Date:  2013-08-22       Impact factor: 7.640

Review 8.  Prostate cancer and bone: the elective affinities.

Authors:  Nadia Rucci; Adriano Angelucci
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.